Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8871785 Antiviral phosphonate analogs

Patent 8871785 was granted and assigned to Gilead Sciences on October, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Gilead Sciences

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88717850

Patent Inventor Names

Lee S. Chong0

Maria Fardis0

Ralph Hirschmann0

Richard L. Mackman0

Rosemarie O'Shea0

Sundaramoorthi Swaninathan0

Thorsten A. Kirschberg0

Vidya K. Prasad0

...

Date of Patent

October 28, 2014

Patent Application Number

138485930

Date Filed

March 21, 2013

Patent Citations Received

‌

US Patent 11801255 Lipid disulfide prodrugs and uses related thereto

‌

US Patent 11975016 2′-substituted-N

‌

US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

‌

US Patent 11690860 Treatment of HCV infected patients with cirrhosis

‌

US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

‌

US Patent 11707480 Highly active compounds against COVID-19

Patent Primary Examiner

‌

Rei Tsang Shiao

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8871785 Antiviral phosphonate analogs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API